epiq Animal Health and KeraVet Bio Collaborate to Market KeraVet Gel for Wound Healing in Animals
Shots:
- epiq Animal Health and KeraVet Bio have entered into a strategic partnership to market wound care animal product, KeraVet Gel
- The partnership will work on supply chain solutions as well as aims at educating & training the animal health community. It benefits KeraVet Bio by offering one ship-to location along with inventory & account management, distribution partners by offering profitable products and veterinarians by offering access to essential products for the best possible care
- KeraVet Gel, a reformulation of KeraStat Gel for humans, consists of a bitterant to reduce 85%+ licking. It is developed for faster wound healing ranging from surgical incisions to more complex, topical wound lesions in dogs and cats
Ref: Businesswire | Image: Zoetis
Related News:- Zoetis Reports Divestiture of its Medicated Feed Additive Portfolio to Phibro Animal Health
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
